Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Auxillium Pharmaceuticals to receive $15 million from Pfizer in Xiaflex partnership
Yahoo/AP
Thursday, January 21, 2010 - 10:20am
tags:
Pfizer, Xiaflex, partnerships, Auxilium
Novartis $214M Deal with GenVec Tests Gene Therapy Waters
BNET Pharma
Thursday, January 21, 2010 - 9:03am
tags:
GenVec, gene therapy, Novartis, partnerships
Will Generex Biotech Be Next to Join the Winner's Circle?
Seeking Alpha
Thursday, January 21, 2010 - 9:02am
tags:
Generex, diabetes, insulin spray
Novartis, Merck KGaA Pills Bring ‘New Horizon’ for MS
Bloomberg
Thursday, January 21, 2010 - 9:01am
tags:
MS, multiple sclerosis, Novartis, Merck KGaA
Pfizer nearly doubles amount spent on e-detailing
Medical Marketing and Media
Thursday, January 21, 2010 - 8:27am
tags:
Pfizer, e-detailing
Inspire Dry Eye Drug Fails Key Test
TheStreet.com
Thursday, January 21, 2010 - 8:26am
tags:
dry eye disease, Inspire
[video] Nothing Generic About Teva [1.6 min]
Marketwatch
Thursday, January 21, 2010 - 7:50am
tags:
generics, Teva Pharmaceuticals
Investors betting heavily on Vivus obesity drug
Marketwatch
Thursday, January 21, 2010 - 7:49am
tags:
Vivus, obesity, Qnexa
Study: orphan drug applications doubled in 2000s
Yahoo/AP
Thursday, January 21, 2010 - 7:48am
tags:
orphan drugs
EntreMed aims to prevent stock delisting
Bizjournals.com
Thursday, January 21, 2010 - 7:47am
tags:
EntreMed, delisting
Ipsen Buys Inspiration Stake in Hemophilia Alliance
Bloomberg
Thursday, January 21, 2010 - 7:46am
tags:
hemophilia, Ipsen, Inspiration, M&A
Chantix Continues To Be a Cancer on Pfizer
Minyanville
Wednesday, January 20, 2010 - 6:35pm
tags:
Pfizer, smoking cessation, Chantix
Court voids J&J patents in Boston Scientific suit
Yahoo/AP
Wednesday, January 20, 2010 - 6:34pm
tags:
JNJ, patents, lawsuits, Boston Scientific, Cordis
FDA Petitioned To Remove Fibromyalgia Drug
Pharmalot
Wednesday, January 20, 2010 - 6:33pm
tags:
fibromyalgia, FDA, Savella, Cypress Bioscience, Forest Labs
Novartis says 3 drugs approved in Japan
Yahoo/AP
Wednesday, January 20, 2010 - 6:32pm
tags:
Japan, Novartis, Equa, Exforge, Afinitor
GlaxoSmithKline:Open Innovation Strategy To Aid Poor Countries
WSJ Online
Wednesday, January 20, 2010 - 11:02am
tags:
GSK
Biotech VC trends to watch in 2010
Fierce Biotech
Wednesday, January 20, 2010 - 11:01am
tags:
venture capital
BioMarin Pharmaceutical is Poised for a Technical Breakout
Schaeffers Research
Wednesday, January 20, 2010 - 11:00am
tags:
Biomarin
What will pharma do now on health reform?
Fierce Pharma
Wednesday, January 20, 2010 - 10:39am
tags:
healthcare reform
Risperdal Kickback Case: J&J Tried to Freeze Out Lilly; 72% Market Share Not Good Enough!
BNET Pharma
Wednesday, January 20, 2010 - 10:38am
tags:
Risperdal, kickbacks, JNJ, Eli Lilly

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.